Putnam Investments’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-6,257
| Closed | -$621K | – | 971 |
|
|
2019
Q3 | $621K | Sell |
6,257
-236
| -4% | -$22.4K | ﹤0.01% | 791 |
|
|
2019
Q2 | $600K | Sell |
6,493
-226,551
| -97% | -$21.5M | ﹤0.01% | 790 |
|
|
2019
Q1 | $22M | Sell |
233,044
-292,168
| -56% | -$25.6M | 0.05% | 232 |
|
|
2018
Q4 | $33.7M | Buy |
525,212
+363,323
| +224% | +$26.8M | 0.09% | 178 |
|
|
2018
Q3 | $14.5M | Sell |
161,889
-331
| -0.2% | -$29.3K | 0.03% | 315 |
|
|
2018
Q2 | $12.9M | Sell |
162,220
-227,554
| -58% | -$18.9M | 0.03% | 327 |
|
|
2018
Q1 | $34.8M | Buy |
389,774
+33,339
| +9% | +$3.2M | 0.08% | 209 |
|
|
2017
Q4 | $37.2M | Sell |
356,435
-1,842,779
| -84% | -$208M | 0.08% | 196 |
|
|
2017
Q3 | $321M | Sell |
2,199,214
-83,354
| -4% | -$11.4M | 0.74% | 27 |
|
|
2017
Q2 | $296M | Sell |
2,282,568
-847,353
| -27% | -$104M | 0.69% | 30 |
|
|
2017
Q1 | $389M | Sell |
3,129,921
-330,598
| -10% | -$39.6M | 0.91% | 19 |
|
|
2016
Q4 | $401M | Sell |
3,460,519
-49,585
| -1% | -$5.52M | 0.97% | 18 |
|
|
2016
Q3 | $367M | Sell |
3,510,104
-382,689
| -10% | -$41.4M | 0.88% | 26 |
|
|
2016
Q2 | $384M | Buy |
3,892,793
+16,830
| +0.4% | +$1.74M | 0.94% | 18 |
|
|
2016
Q1 | $388M | Buy |
3,875,963
+285,116
| +8% | +$29.4M | 0.92% | 17 |
|
|
2015
Q4 | $430M | Buy |
3,590,847
+174,232
| +5% | +$20.2M | 0.97% | 20 |
|
|
2015
Q3 | $370M | Sell |
3,416,615
-576,051
| -14% | -$71.5M | 0.83% | 22 |
|
|
2015
Q2 | $462M | Buy |
3,992,666
+404,950
| +11% | +$46.3M | 0.93% | 17 |
|
|
2015
Q1 | $414M | Buy |
3,587,716
+184,404
| +5% | +$22M | 0.82% | 20 |
|
|
2014
Q4 | $381M | Buy |
3,403,312
+31,757
| +0.9% | +$3.35M | 0.78% | 21 |
|
|
2014
Q3 | $320M | Sell |
3,371,555
-350,122
| -9% | -$31.6M | 0.68% | 28 |
|
|
2014
Q2 | $320M | Buy |
3,721,677
+120,503
| +3% | +$9.16M | 0.69% | 25 |
|
|
2014
Q1 | $251M | Sell |
3,601,174
-109,362
| -3% | -$8.66M | 0.57% | 41 |
|
|
2013
Q4 | $313M | Sell |
3,710,536
-157,524
| -4% | -$12.5M | 0.75% | 21 |
|
|
2013
Q3 | $298M | Buy |
3,868,060
+321,648
| +9% | +$22.5M | 0.8% | 19 |
|
|
2013
Q2 | $207M | Buy |
+3,546,412
| New | +$213M | 0.6% | 35 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Putnam Investments's CELG Position: Q4 2019 in Review
Putnam Investments sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,257 shares — an estimated $621K sold.
Putnam Investments first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $462M in Q2 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Putnam Investments reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Putnam Investments sold 6,257 Celgene Corp shares in Q4 2019, an estimated $621K.
- Putnam Investments first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Putnam Investments's Celgene Corp position peaked at $462M in Q2 2015.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Putnam Investments's 13F filing for Q4 2019, filed 14 Feb 2020.